Cathay General Bancorp:企業の戦略・SWOT・財務情報

◆英語タイトル:Cathay General Bancorp - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15562
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Cathay General Bancorp – Strategy, SWOT and Corporate Finance Report
Summary

Cathay General Bancorp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cathay General Bancorp (CGB) is a bank holding company that offers a wide range of financial products and services to individuals, professionals, and small to medium-sized businesses through its wholly-owned subsidiary, Cathay Bank. Its portfolio of products includes saving accounts, individual retirement accounts, business accounts, certificates of deposit, checking and time deposits, debit cards, and credit cards. The bank offers loan solutions for real estate, commercial purpose, personal purpose, home improvement, automobile, and other installment and term loans. CGB provides various commercial banking services such as cash management, foreign exchange, real estate and construction financing, and international banking. The bank also offers a range of wealth management and investment products and services. It operates a network of branch offices located in California, New York, Massachusetts, Texas, Nevada, Washington, Illinois, Maryland, New Jersey, and Hong Kong, and representative offices in Shanghai and Taipei. CGB is headquartered in Los Angeles, California, the US.

Scope

- Detailed information on Cathay General Bancorp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cathay General Bancorp in the form of a SWOT analysis
- An in-depth view of the business model of Cathay General Bancorp including a breakdown and examination of key business segments
- Intelligence on Cathay General Bancorp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cathay General Bancorp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cathay General Bancorp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cathay General Bancorp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cathay General Bancorp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Cathay General Bancorp: Company Overview
Cathay General Bancorp: Overview and Key Facts
Cathay General Bancorp: Overview
Cathay General Bancorp: Key Facts
Cathay General Bancorp: Key Employees
Cathay General Bancorp: Key Employee Biographies
Cathay General Bancorp: Major Products and Services
Cathay General Bancorp: Company History
Cathay General Bancorp: Management Statement
Cathay General Bancorp: Locations and Subsidiaries
Cathay General Bancorp: Key Competitors
Cathay General Bancorp: Company Analysis
Cathay General Bancorp: Business Description
Cathay General Bancorp: SWOT Analysis
Cathay General Bancorp: SWOT Overview
Cathay General Bancorp: Strengths
Cathay General Bancorp: Weaknesses
Cathay General Bancorp: Opportunities
Cathay General Bancorp: Threats
Cathay General Bancorp: Corporate Financial Deals Activity
Cathay General Bancorp: Financial Deals Overview
Cathay General Bancorp: Targets and Partners
Cathay General Bancorp: Top Deals 2015 – 2019YTD*
Cathay General Bancorp: Advisors
Cathay General Bancorp: Top Legal Advisors
Cathay General Bancorp: Top Financial Advisors
Cathay General Bancorp: Mergers and Acquisitions
Cathay General Bancorp: Recent Developments
Cathay General Bancorp: News and Events Summary
Cathay General Bancorp: Contracts
Cathay General Bancorp: Corporate Governance
Cathay General Bancorp: Financial Deals
Cathay General Bancorp: Financial Performance
Cathay General Bancorp: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Cathay General Bancorp: Key Facts
Table 2: Cathay General Bancorp: Key Employees
Table 3: Cathay General Bancorp: Company History
Table 4: Cathay General Bancorp: Locations and Subsidiaries
Table 5: Cathay General Bancorp: Key Competitors
Table 6: Cathay General Bancorp: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Cathay General Bancorp: M&A Average Deal Size - Value (US$m)
Table 8: Cathay General Bancorp: Targets and Partners
Table 9: Cathay General Bancorp: Top Deals 2015 - 2019YTD*
Table 10: Cathay General Bancorp: Legal Advisor Ranking by Value (US$m)
Table 11: Cathay General Bancorp: Financial Advisor Ranking by Value (US$m)
Table 12: Cathay General Bancorp: M&A Volume and Value Trend (2015 - YTD*2019)
Table 13: Cathay General Bancorp: M&A Activity by Geography (2015 - YTD*2019)
Table 14: Cathay General Bancorp: News and Events Summary
Table 15: Cathay General Bancorp: Contracts
Table 16: Cathay General Bancorp: Corporate Governance
Table 17: Cathay General Bancorp: Financial Deals
Table 18: Cathay General Bancorp: Financial Performance
Table 19: Cathay General Bancorp: Strategy and Operations

List of Figures
Figure 1: Cathay General Bancorp: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 2: Cathay General Bancorp: M&A Average Deal Size - Value (US$m)
Figure 3: Cathay General Bancorp: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 4: Cathay General Bancorp: M&A Activity by Geography (2015 - YTD*2019)

★海外企業調査レポート[Cathay General Bancorp:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Northwest Pipe Co (NWPX):企業の財務・戦略的SWOT分析
    Northwest Pipe Co (NWPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ya-Man Ltd:企業の戦略・SWOT・財務分析
    Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report Summary Ya-Man Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cellumed Co Ltd (049180)-医療機器分野:企業M&A・提携分析
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc, is a biotechnology company that develops bone graft substitution based on human tissue graft. The company’s portfolio encompasses spinal fixation systems; joint replacement and navigation system; bone powder; DBM gel; bio-clearant, an …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Hagoromo Foods Corporation:企業の戦略・SWOT・財務情報
    Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Air Liquide SA (AI):医療機器:M&Aディール及び事業提携情報
    Summary Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industrial and health care sectors. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in industries, including ste …
  • Prolung Inc (LUNG):医療機器:M&Aディール及び事業提携情報
    Summary Prolung Inc(Prolung) formerly known as Fresh Medical Laboratories Inc, is a medical device company that offers diagnostic services. The company offers electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists o …
  • Cloud Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cloud Pharmaceuticals Inc (Cloud Pharmaceuticals), formerly TeraDiscoveries Inc is a drug development company that designs and develops novel drugs and therapies for cancer, inflammation, CNS disorders, and rare diseases. The company offers molecular designs of ligands through its proprietar …
  • Changmao Biochemical Engineering Co., Ltd
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Daisy IT Group Ltd:企業の戦略的SWOT分析
    Daisy IT Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Butler National Corporation:企業の戦略・SWOT・財務情報
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Muhibbah Engineering (M) Bhd:企業の戦略・SWOT・財務情報
    Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report Summary Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BioVentrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company offers revivent myocardial anchoring systems, a device that restores the size, volume and resulting function of the left ventricle for improving cardiac function in …
  • Allscripts Healthcare Solutions, Inc.:企業のM&A・事業提携・投資動向
    Allscripts Healthcare Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allscripts Healthcare Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Abcam Plc (ABC)-医療機器分野:企業M&A・提携分析
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • CytRx Corp (CYTR):製薬・医療:M&Aディール及び事業提携情報
    Summary CytRx Corp (CytRx) is a clinical state is a biopharmaceutical company focusing on the research and development of novel treatments for cancer. The company’s oncology based product comprises of its lead drug product candidate, aldoxorubicin (formerly INNO-206). Aldoxorubicin is a pro-drug of …
  • Xenon Pharmaceuticals Inc (XENE):企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • Naver Corp (035420):企業の財務・戦略的SWOT分析
    Naver Corp (035420) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆